HealthStream (HSTM) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
12 May, 2026Executive summary
Achieved record Q1 2026 revenue of $81.2 million, up 10.5% year-over-year, with adjusted EBITDA of $20.1 million, a 24.1% increase, and net income of $5.9 million, up 36.4% from Q1 2025.
Operating income rose 71.6% to $7.5 million; EPS increased to $0.20 from $0.14 year-over-year.
Growth was driven by organic expansion and recent acquisitions, including Virsys12 and MissionCare Collective.
Maintains a strong cash balance of $66.5 million, no long-term debt, and an untapped credit facility.
Michael M. Collier promoted to COO & EVP, leading enterprise operations and AI transformation.
Financial highlights
Subscription revenues increased by $7.6 million (10.7%) to $78.4 million; professional services rose 4% to $2.8 million.
Gross margin improved to 65.8% from 65.3% year-over-year; adjusted EBITDA margin was 24.8%.
Operating margin improved to 9.3% from 6.0% year-over-year.
Cash, cash equivalents, and marketable securities totaled $66.5 million as of March 31, 2026.
Market capitalization stood at ~$713.9 million as of May 5, 2026.
Outlook and guidance
Reaffirmed 2026 full-year guidance: revenue $323–$330 million, net income $20.4–$22.8 million, adjusted EBITDA $73–$77 million.
Capital expenditures for 2026 projected at $31–$34 million.
Guidance excludes impacts from future acquisitions, dispositions, or asset impairments and assumes stable economic conditions.
Sufficient liquidity is anticipated to fund operations, dividends, share repurchases, and capital expenditures for at least the next 12 months.
39% of $687 million in remaining performance obligations to be recognized over the next 12 months.
Latest events from HealthStream
- Shareholders will vote virtually on directors, auditor ratification, and executive pay, focusing on governance and ESG.HSTM
Proxy filing10 Apr 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay set for May 28, 2026.HSTM
Proxy filing10 Apr 2026 - Record 2025 revenue and EBITDA growth, with 2026 guidance projecting further expansion.HSTM
Q4 202513 Mar 2026 - Q2 2024 revenue up 3.4% to $71.6M, guidance reaffirmed, and SaaS platform growth continues.HSTM
Q2 20243 Feb 2026 - Record Q3 revenue, profit growth, and raised guidance highlight strong operational momentum.HSTM
Q3 202419 Jan 2026 - Strong SaaS growth, acquisitions, and platform innovation drive robust 2024 results and 2025 outlook.HSTM
Q4 202423 Dec 2025 - 2025 proxy covers director elections, auditor ratification, executive pay, and ESG priorities.HSTM
Proxy Filing1 Dec 2025 - Annual meeting to address director elections, pay, and auditor ratification.HSTM
Proxy Filing1 Dec 2025 - Record Q2 2025 revenue, profit growth, and a $25M share buyback highlight strong results.HSTM
Q2 202523 Nov 2025